Posted in In a discussion about the distribution and use of Remdesivir for the treatment of COVID-19 during the Democracy Now segment, Amy Goodman asks Achal Prabhala, “who profits, who gets access, and how important is this drug? How does Prabhala respond? What are the parallels between access to Remdesivir and access to COVID-19 vaccines?
